UK Markets open in 5 hrs 52 mins
  • NIKKEI 225

    27,977.02
    +155.26 (+0.56%)
     
  • HANG SENG

    23,777.18
    +301.92 (+1.29%)
     
  • GOLD FUTURES

    1,772.30
    -1.30 (-0.07%)
     
  • DOW

    34,483.72
    -652.22 (-1.86%)
     
  • BTC-GBP

    42,919.72
    -450.85 (-1.04%)
     
  • CMC Crypto 200

    1,467.93
    +0.00 (+0.00%)
     
  • Nasdaq

    15,537.69
    -383.91 (-2.41%)
     
  • ^FTAS

    4,025.87
    -138.90 (-3.34%)
     

Why the Earnings Surprise Streak Could Continue for West Pharmaceutical (WST)

  • Oops!
    Something went wrong.
    Please try again later.
·3-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? West Pharmaceutical Services (WST), which belongs to the Zacks Medical - Dental Supplies industry, could be a great candidate to consider.

This medical device company has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 42.87%.

For the most recent quarter, West Pharmaceutical was expected to post earnings of $1.74 per share, but it reported $2.46 per share instead, representing a surprise of 41.38%. For the previous quarter, the consensus estimate was $1.42 per share, while it actually produced $2.05 per share, a surprise of 44.37%.

Price and EPS Surprise

With this earnings history in mind, recent estimates have been moving higher for West Pharmaceutical. In fact, the Zacks Earnings ESP (Expected Surprise Prediction) for the company is positive, which is a great sign of an earnings beat, especially when you combine this metric with its nice Zacks Rank.

Our research shows that stocks with the combination of a positive Earnings ESP and a Zacks Rank #3 (Hold) or better produce a positive surprise nearly 70% of the time. In other words, if you have 10 stocks with this combination, the number of stocks that beat the consensus estimate could be as high as seven.

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a version of the Zacks Consensus whose definition is related to change. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

West Pharmaceutical currently has an Earnings ESP of +1.93%, which suggests that analysts have recently become bullish on the company's earnings prospects. This positive Earnings ESP when combined with the stock's Zacks Rank #2 (Buy) indicates that another beat is possibly around the corner.

When the Earnings ESP comes up negative, investors should note that this will reduce the predictive power of the metric. But, a negative value is not indicative of a stock's earnings miss.

Many companies end up beating the consensus EPS estimate, but that may not be the sole basis for their stocks moving higher. On the other hand, some stocks may hold their ground even if they end up missing the consensus estimate.

Because of this, it's really important to check a company's Earnings ESP ahead of its quarterly release to increase the odds of success. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

West Pharmaceutical Services, Inc. (WST) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting